MyAverix Finance MyAverix Finance

BE · Other

TISSUE THERAPIES (1TT)

Other

TISSUE THERAPIES (1TT) is listed on BE in the Other sector. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for 1TT

P/E ratio
18.00

TISSUE THERAPIES (1TT) — FAQ

What is 1TT's P/E ratio?

The price-to-earnings (P/E) ratio for TISSUE THERAPIES (1TT) is 18.00 (data as of 2026-03-22).

Does TISSUE THERAPIES pay a dividend?

Dividend yield is not available in the current snapshot for TISSUE THERAPIES (1TT). Check the MyAverix Finance app for the latest dividend data.

What sector is TISSUE THERAPIES in?

TISSUE THERAPIES (1TT) is classified in the Other sector.

What exchange is 1TT listed on?

1TT is listed on BE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Other companies

Adobe Inc (ADB) AIA GROUP (7A2) Amazon.com Inc (AMZ) AMERICAN EXPRESS (AEC1) Apple Inc (APC) Berkshire Hathaway Inc (BRYN) EXXON MOBIL (XONA) Honeywell International Inc (ALD)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play